Associate, Clinical Development Operations and Project Management

About Atisama Therapeutics Atisama Therapeutics is a clinical-stage biotechnology company pioneering splice-switching oligonucleotide (SSO) therapies that return gene transcription pathways to their optimal form, restoring the molecular balance from disease towards lasting health. Our lead asset, RB042, is an inhaled SSO targeting the Receptor for Advanced Glycation End-products (RAGE). It converts RAGE from its pro-inflammatory isoform to its protective, anti-inflammatory counterpart, a precis…